DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Molecular Imaging Homepage

CereMetrix Silver neuroimaging analytics platform scores FDA approval Quantifies brain function down to the voxel level

New PET imaging agent predicts tumor response to lung cancer drug Could lead to better patient management and outcomes

PET beats SPECT for detecting coronary artery disease: study Detected 79 percent of severe obstructive cases versus 70 percent

PET/MR and the future of pediatric chemotherapy Dr. Ashok Joseph Theruvath, postdoctoral research fellow in the Molecular Imaging Program at the Stanford School of Medicine discusses promising research for assessing pediatric chemo outcomes

Availity announces debut of pre-clearance service at HIMSS Confirms imaging authorization in minutes and ensures patient payments prior to visit

NTP Radioisotopes facility resumes production following hydrogen leak Produces Mo-99 for US, European and other global customers

NCCN adds Axumin to guidelines for prostate cancer treatment Enhances support for imaging agent from private payors

Lisa Hazen ARRT appoints new Nuclear Medicine Technology (NMT) Relationship Manager

SHINE completes Building One of medical isotope production facility Facility is projected to become domestic source for Mo-99 production in US

Ian Wilson ImaginAb appoints chief operating officer

Philips steps up molecular imaging value proposition at SNMMI

by John W. Mitchell , Senior Correspondent
Lower doses, faster scan times, higher sensitivity to find smaller lesions, and equipment affordability are on display by Philips through several new products, platforms and software announcements at SNMMI 2017. The annual meeting to showcase nuclear medicine and molecular imaging accomplishments is being held in Denver this week.

"The full potential of molecular imaging is now becoming a reality, and it's really exciting," Kirill Shalyaev, vice president and general manager of advanced molecular imaging at Philips Healthcare America, told HCB News.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

His enthusiasm was very much evident at SNMMI this year as he and his colleagues presented innovations ranging from more powerful digital equipment to analytic software. Phillips is also presenting innovation forums on topics including digital PET applications in sports medicine and theranostics.

Top in its showcase this year is the Philips Vereos Digital PET/CT, which the company said is the world’s first fully digital PET/CT system. Philips worked in collaboration with the Wright Center of Innovation in Biomedical Imaging at Wexner Medical Center at Ohio State University on clinical application of the digital PET technology.

For example, scan times using the Vereos are up to ten times faster, according to Shalyaev. Also, the unit accomplishes this using about half the PET dose, which results in improved small lesion detectability.

The company also had its Astonish TF technology for enhanced image contrast, resolution, and quality on display with its Ingenuity TF PET/CT. The system features Philips' proprietary xPand5 quantification tools to assist in measuring and monitoring disease progression.

These technologies join CT advances, such as iPatient, iDose and metal artifact reduction for implants (O-MAR), to drive confidence and consistency through personalized patient-centric workflow.

Another Philip’s platform on display at the meeting was its IntelliSpace Portal 9.0. This latest edition of Philips' comprehensive, advanced visualization and analysis platform provides quantitative tumor tracking and treatment response tools.

It offers a streamlined workflow for follow‐up and analysis in oncology cases. IntelliSpace Portal 9.0 also provides enterprise‐wide access to a comprehensive suite of molecular imaging processing and review applications for general nuclear medicine, SPECT, SPECT/CT and PET/CT.

Phillips is also working on fine-tuning its SPECT solutions. Shalyaev noted the market is changing, with pressures on cost and reimbursement.

The company is focusing on its two camera units that are easier to site — about half the floor space as the previous model — and easier to service. This helps offer a better return on investment for nuclear medicine departments.

Molecular Imaging Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.